about
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices a...
Read More
350.78
0.29
(0.08%)
3.3M
XNYS Volume
High volume today
XNYS 16 Jan, 2026 4:30 PM (EST)
Analyst Downgrade
Baird downgrades Penumbra to a 'Neutral' rating; considers it overvalued compared to its Fair Value
See details
High Financial Strength
Mid Valuation
Technically Moderately Bullish
Strong Performer, Getting Expensive
These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying
View Similar
Embed DVM
Penumbra Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..